KRISTEN MCGRONAN: Open Payments
NPI 1255004107 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$676 in 27 payments from 17 companies in 2025. Trend: 2023 $594 · 2024 $118 · 2025 $676
Food & beverage: $632Education: $43
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $213 |
| Janssen Biotech, Inc. | 2 | $95 |
| Daiichi Sankyo Inc. | 2 | $49 |
| Eisai Inc. | 1 | $31 |
| Astellas Pharma US Inc | 1 | $31 |
| Genmab U.S., Inc. | 1 | $31 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
| PFIZER INC. | 1 | $27 |
| Alexion Pharmaceuticals, Inc. | 1 | $27 |
| Iovance Biotherapeutics, Inc. | 1 | $22 |
Products named: ENHERTU, RYBREVANT, IMFINZI, CALQUENCE, Lenvima, Vyloy, Epkinly, Nubeqa.
Industry payments across TN — which companies pay providers there.
